Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer : Internal Medicine News

Links shared publicly online about this topic.

  • 240
    total visits

Bevacizumab Halves Progression Risk in Recurrent Ovarian Cancer : Internal Medicine News

internalmedicinenews.com

Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre

View full resource at internalmedicinenews.com

Tags: Heart, Cancer, Colorectal Cancer Medication, Ovarian Cancer, Women's Health, Avastin, News, Medical

  • Share

Most Recently Shared on June 5, 2011 at 11:58 pm By:

MiriamETucker Miriam E. Tucker

RT @IntMedNews: Bevacizumab Halves Progression Risk in Recurrent Ovarian #Cancer http://bit.ly/ipBNsP

11 months ago...

Advertisement